NCT00653822View on ClinicalTrials.gov

A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Pharmacokinetics of Alefacept
Interventions
DRUG

alefacept

IC and SC

DRUG

placebo

IV and SC

Trial Locations (1)

91206

Glendale

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY